Initial imaging findings using [18f]GE-148 ([18F]FACBC) PET/CT in subjects with primary prostate cancer. Background: This study evaluated trx patterns of AIs sunitinib (SU), sorafenib (SOR), and ...
An individualized dose/schedule strategy for sunitinib in metastatic renal cell cancer (mRCC) on progression-free survival (PFS): Correlation with dynamic microbubble ultrasound (DCE-US) data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results